Skip to main content
Erschienen in: Journal of General Internal Medicine 11/2012

01.11.2012 | Original Research

They Don’t Know What They Don’t Know: Internal Medicine Residents’ Knowledge and Confidence in Urine Drug Test Interpretation for Patients with Chronic Pain

verfasst von: Joanna L. Starrels, MD, MS, Aaron D. Fox, MD, MS, Hillary V. Kunins, MD, MPH, MS, Chinazo O. Cunningham, MD, MS

Erschienen in: Journal of General Internal Medicine | Ausgabe 11/2012

Einloggen, um Zugang zu erhalten

ABSTRACT

BACKGROUND

Urine drug testing (UDT) can help identify misuse or diversion of opioid medications among patients with chronic pain. However, misinterpreting results can lead to false reassurance or erroneous conclusions about drug use.

OBJECTIVE

To examine the relationship between resident physicians’ knowledge about UDT interpretation and confidence in their ability to interpret UDT results.

DESIGN

Cross-sectional survey.

PARTICIPANTS

Internal medicine residents in a university health system in the Bronx, from 2010 to 2011.

MAIN MEASURES

We assessed knowledge using a 7-item scale (UDT knowledge score), and confidence in UDT interpretation using a single statement (“I feel confident in my ability to interpret the results of urine drug tests”). We conducted chi-square tests, t-tests, and logistic regression to determine the association between knowledge and confidence, and in exploratory analyses to examine whether resident characteristics (gender, training level, and UDT use) moderated the relationship between knowledge and confidence.

KEY RESULTS

Among 99 residents, the mean UDT knowledge score was 3.0 out of 7 (SD 1.2). Although 55 (56 %) of residents felt confident in their ability to interpret UDT results, 40 (73 %) of confident residents had a knowledge score of 3 or lower. Knowledge score was not associated with confidence among the full sample or when stratified by training level or UDT use. The association between knowledge and confidence differed significantly by gender (interaction term p < 0.01). Adjusting for training level and UDT use, knowledge was positively associated with confidence among females (AOR 1.79, 95 % CI: 1.06, 3.30), and negatively associated with confidence among males (AOR 0.47, 95 % CI: 0.23, 0.98).

CONCLUSIONS

Despite poor knowledge about UDT interpretation, most resident physicians felt confident in their ability to interpret UDT results. Gender differences warrant further exploration, but even confident physicians who use UDT should evaluate their proficiency in interpreting UDT results. Educational initiatives should emphasize the complexities of UDT interpretation.
Literatur
1.
Zurück zum Zitat Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS) Highlights-- 2006 National Admissions to Substance Abuse Treatment Services. OAS Series #S-40, DHHS Publication No. (SMA) 08–4313, Rockville, MD, 2007; http://www.samhsa.gov/data/TEDS2k6highlights/TOC.htm. Accessed 10 July 2012. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS) Highlights-- 2006 National Admissions to Substance Abuse Treatment Services. OAS Series #S-40, DHHS Publication No. (SMA) 08–4313, Rockville, MD, 2007; http://​www.​samhsa.​gov/​data/​TEDS2k6highlight​s/​TOC.​htm. Accessed 10 July 2012.
2.
Zurück zum Zitat Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006;15:618–27.PubMedCrossRef Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006;15:618–27.PubMedCrossRef
3.
Zurück zum Zitat Centers for Disease Control and Prevention. Vital Signs: Overdoses of Prescription Opioid Pain Relievers-- United States, 1999–2008. In: MMWR Morb Mortal Wkly Rep. 4 Nov 2011 ed:1487–92. Centers for Disease Control and Prevention. Vital Signs: Overdoses of Prescription Opioid Pain Relievers-- United States, 1999–2008. In: MMWR Morb Mortal Wkly Rep. 4 Nov 2011 ed:1487–92.
4.
Zurück zum Zitat Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–30.PubMedCrossRef Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–30.PubMedCrossRef
6.
Zurück zum Zitat Trescot AM, Helm S, Hansen H, et al. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician. 2008;11:S5–62.PubMed Trescot AM, Helm S, Hansen H, et al. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician. 2008;11:S5–62.PubMed
8.
Zurück zum Zitat McLellan AT, Turner B. Prescription opioids, overdose deaths, and physician responsibility. JAMA. 2008;300:2672–3.PubMedCrossRef McLellan AT, Turner B. Prescription opioids, overdose deaths, and physician responsibility. JAMA. 2008;300:2672–3.PubMedCrossRef
9.
Zurück zum Zitat Atluri S, Sudarshan G. Evaluation of abnormal urine drug screens among patients with chronic non-malignant pain treated with opioids. Pain Physician. 2003;6:407–9.PubMed Atluri S, Sudarshan G. Evaluation of abnormal urine drug screens among patients with chronic non-malignant pain treated with opioids. Pain Physician. 2003;6:407–9.PubMed
10.
Zurück zum Zitat Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS. Validity of self-reported drug use in chronic pain patients. Clin J Pain. 1999;15:184–91.PubMedCrossRef Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS. Validity of self-reported drug use in chronic pain patients. Clin J Pain. 1999;15:184–91.PubMedCrossRef
11.
Zurück zum Zitat Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain. 2002;18:S76–82.PubMedCrossRef Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain. 2002;18:S76–82.PubMedCrossRef
12.
Zurück zum Zitat Berndt S, Maier C, Schütz H-W. Polymedication and medication compliance in patients with chronic non-malignant pain. Pain. 1993;52:331–9.PubMedCrossRef Berndt S, Maier C, Schütz H-W. Polymedication and medication compliance in patients with chronic non-malignant pain. Pain. 1993;52:331–9.PubMedCrossRef
13.
Zurück zum Zitat Schuckman H, Hazelett S, Powell C, Steer S. A validation of self-reported substance use with biochemical testing among patients presenting to the emergency department seeking treatment for backache, headache, and toothache. Subst Use Misuse. 2008;43:589–95.PubMedCrossRef Schuckman H, Hazelett S, Powell C, Steer S. A validation of self-reported substance use with biochemical testing among patients presenting to the emergency department seeking treatment for backache, headache, and toothache. Subst Use Misuse. 2008;43:589–95.PubMedCrossRef
14.
Zurück zum Zitat Katz NP, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97:1097–102.PubMedCrossRef Katz NP, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97:1097–102.PubMedCrossRef
15.
Zurück zum Zitat Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152:712–20.PubMed Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152:712–20.PubMed
16.
Zurück zum Zitat Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manag. 2004;27:260–7.CrossRef Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manag. 2004;27:260–7.CrossRef
17.
Zurück zum Zitat Gilbert JW, Wheeler GR, Mick GE, et al. Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky. Pain physician. 13:167–86. Gilbert JW, Wheeler GR, Mick GE, et al. Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky. Pain physician. 13:167–86.
18.
Zurück zum Zitat Reisfield GM, Salazar E, Bertholf RL. Rational use and interpretation of urine drug testing in chronic opioid therapy. Ann Clin Lab Sci. 2007;37:301–14.PubMed Reisfield GM, Salazar E, Bertholf RL. Rational use and interpretation of urine drug testing in chronic opioid therapy. Ann Clin Lab Sci. 2007;37:301–14.PubMed
19.
Zurück zum Zitat Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008;83:66–76.PubMedCrossRef Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008;83:66–76.PubMedCrossRef
21.
Zurück zum Zitat Melanson SE, Kredlow MI, Jarolim P, Melanson SEF, Kredlow MI, Jarolim P. Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective. Clin Chem Lab Med. 2009;47:971–6.PubMedCrossRef Melanson SE, Kredlow MI, Jarolim P, Melanson SEF, Kredlow MI, Jarolim P. Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective. Clin Chem Lab Med. 2009;47:971–6.PubMedCrossRef
22.
Zurück zum Zitat Reisfield GM, Webb FJ, Bertholf RL, Sloan PA, Wilson GR. Family physicians' proficiency in urine drug test interpretation. J Opioid Manag. 2007;3. Reisfield GM, Webb FJ, Bertholf RL, Sloan PA, Wilson GR. Family physicians' proficiency in urine drug test interpretation. J Opioid Manag. 2007;3.
23.
Zurück zum Zitat Levy S, Harris SK, Sherritt L, Angulo M, Knight JR. Drug testing of adolescents in ambulatory medicine: physician practices and knowledge. Arch Pediatr Adolesc Med. 2006;160:146–50.PubMedCrossRef Levy S, Harris SK, Sherritt L, Angulo M, Knight JR. Drug testing of adolescents in ambulatory medicine: physician practices and knowledge. Arch Pediatr Adolesc Med. 2006;160:146–50.PubMedCrossRef
24.
Zurück zum Zitat Duffy FD, Holmboe ES. Self-assessment in lifelong learning and improving performance in practice: physician know thyself. JAMA. 2006;296:1137–9.PubMedCrossRef Duffy FD, Holmboe ES. Self-assessment in lifelong learning and improving performance in practice: physician know thyself. JAMA. 2006;296:1137–9.PubMedCrossRef
25.
Zurück zum Zitat Davis DA, Mazmanian PE, Fordis M, Van Harrison R, Thorpe KE, Perrier L. Accuracy of physician self-assessment compared with observed measures of competence: a systematic review. JAMA. 2006;296:1094–102.PubMedCrossRef Davis DA, Mazmanian PE, Fordis M, Van Harrison R, Thorpe KE, Perrier L. Accuracy of physician self-assessment compared with observed measures of competence: a systematic review. JAMA. 2006;296:1094–102.PubMedCrossRef
26.
Zurück zum Zitat Blanch DC, Hall JA, Roter DL, Frankel RM. Medical student gender and issues of confidence. Patient Educ Couns. 2008;72:374–81.PubMedCrossRef Blanch DC, Hall JA, Roter DL, Frankel RM. Medical student gender and issues of confidence. Patient Educ Couns. 2008;72:374–81.PubMedCrossRef
27.
Zurück zum Zitat Lundeberg MA. Highly Confident, but Wrong: Gender Differences and Similarities in Confidence Judgments. Annual Meeting of the American Educational Research Association. San Francisco, CA, 1992; http://eric.ed.gov/PDFS/ED347899.pdf Accessed 10 July 2012. Lundeberg MA. Highly Confident, but Wrong: Gender Differences and Similarities in Confidence Judgments. Annual Meeting of the American Educational Research Association. San Francisco, CA, 1992; http://​eric.​ed.​gov/​PDFS/​ED347899.​pdf Accessed 10 July 2012.
28.
Zurück zum Zitat Nomura K, Yano E, Fukui T. Gender differences in clinical confidence: a nationwide survey of resident physicians in Japan. Acad Med. 85:647–53. Nomura K, Yano E, Fukui T. Gender differences in clinical confidence: a nationwide survey of resident physicians in Japan. Acad Med. 85:647–53.
29.
Zurück zum Zitat Harris JM Jr, Fulginiti JV, Gordon PR, et al. KnowPain-50: a tool for assessing physician pain management education. Pain Med. 2008;9:542–54.PubMedCrossRef Harris JM Jr, Fulginiti JV, Gordon PR, et al. KnowPain-50: a tool for assessing physician pain management education. Pain Med. 2008;9:542–54.PubMedCrossRef
30.
Zurück zum Zitat Yanni LM, Weaver MF, Johnson BA, Morgan LA, Harrington SE, Ketchum JM. Management of chronic nonmalignant pain: a needs assessment in an internal medicine resident continuity clinic. J Opioid Manag. 2008;4:201–11.PubMedCrossRef Yanni LM, Weaver MF, Johnson BA, Morgan LA, Harrington SE, Ketchum JM. Management of chronic nonmalignant pain: a needs assessment in an internal medicine resident continuity clinic. J Opioid Manag. 2008;4:201–11.PubMedCrossRef
31.
Zurück zum Zitat Reisfield GM. Urine drug test interpretation: what do physicians know? J Opioid Manag. 2007;3:80–6.PubMed Reisfield GM. Urine drug test interpretation: what do physicians know? J Opioid Manag. 2007;3:80–6.PubMed
32.
Zurück zum Zitat Berner ES, Graber ML. Overconfidence as a cause of diagnostic error in medicine. Am J Med. 2008;121:S2–23.PubMedCrossRef Berner ES, Graber ML. Overconfidence as a cause of diagnostic error in medicine. Am J Med. 2008;121:S2–23.PubMedCrossRef
33.
Zurück zum Zitat Christo PJ, Manchikanti L, Ruan X, et al. Urine drug testing in chronic pain. Pain Physician. 2011;14:123–43.PubMed Christo PJ, Manchikanti L, Ruan X, et al. Urine drug testing in chronic pain. Pain Physician. 2011;14:123–43.PubMed
34.
Zurück zum Zitat Cone EJ, Caplan YH, Cone EJ, Caplan YH. Urine toxicology testing in chronic pain management. Postgraduate Med. 2009;121:91–102.CrossRef Cone EJ, Caplan YH, Cone EJ, Caplan YH. Urine toxicology testing in chronic pain management. Postgraduate Med. 2009;121:91–102.CrossRef
35.
Zurück zum Zitat Isaacson JH, Fleming M, Kraus M, Kahn R, Mundt M. A national survey of training in substance use disorders in residency programs. J Stud Alcohol. 2000;61:912–5.PubMed Isaacson JH, Fleming M, Kraus M, Kahn R, Mundt M. A national survey of training in substance use disorders in residency programs. J Stud Alcohol. 2000;61:912–5.PubMed
36.
Zurück zum Zitat Fleming MF, Manwell LB, Kraus M, Isaacson JH, Kahn R, Stauffacher EA. Who teaches residents about the prevention and treatment of substance use disorders? A national survey. J Fam Pract. 1999;48:725–9.PubMed Fleming MF, Manwell LB, Kraus M, Isaacson JH, Kahn R, Stauffacher EA. Who teaches residents about the prevention and treatment of substance use disorders? A national survey. J Fam Pract. 1999;48:725–9.PubMed
37.
Zurück zum Zitat Miller NS, Sheppard LM, Colenda CC, Magen J. Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders. Acad Med. 2001;76:410–8.PubMedCrossRef Miller NS, Sheppard LM, Colenda CC, Magen J. Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders. Acad Med. 2001;76:410–8.PubMedCrossRef
38.
Zurück zum Zitat Lynch JR, Schmale GA, Schaad DC, Leopold SS. Important demographic variables impact the musculoskeletal knowledge and confidence of academic primary care physicians. J Bone Joint Surg Am. 2006;88:1589–95.PubMedCrossRef Lynch JR, Schmale GA, Schaad DC, Leopold SS. Important demographic variables impact the musculoskeletal knowledge and confidence of academic primary care physicians. J Bone Joint Surg Am. 2006;88:1589–95.PubMedCrossRef
39.
Zurück zum Zitat Haywood BL, Porter SL, Grana WA. Assessment of musculoskeletal knowledge in primary care residents. Am J Orthop (Belle Mead NJ). 2006;35:273–5. Haywood BL, Porter SL, Grana WA. Assessment of musculoskeletal knowledge in primary care residents. Am J Orthop (Belle Mead NJ). 2006;35:273–5.
40.
Zurück zum Zitat Pergolizzi J, Pappagallo M, Stauffer J, et al. The role of urine drug testing for patients on opioid therapy. Pain Pract. 2010;10:497–507.PubMedCrossRef Pergolizzi J, Pappagallo M, Stauffer J, et al. The role of urine drug testing for patients on opioid therapy. Pain Pract. 2010;10:497–507.PubMedCrossRef
41.
Zurück zum Zitat Bornstein BH, Emler AC. Rationality in medical decision making: a review of the literature on doctors' decision-making biases. J Eval Clin Pract. 2001;7:97–107.PubMedCrossRef Bornstein BH, Emler AC. Rationality in medical decision making: a review of the literature on doctors' decision-making biases. J Eval Clin Pract. 2001;7:97–107.PubMedCrossRef
42.
Zurück zum Zitat Shults TF. The Medical Review Officer Handbook, Ninth Edition. Research Triangle Park, NC: Quadrangle Research, LLC; 2009. Shults TF. The Medical Review Officer Handbook, Ninth Edition. Research Triangle Park, NC: Quadrangle Research, LLC; 2009.
Metadaten
Titel
They Don’t Know What They Don’t Know: Internal Medicine Residents’ Knowledge and Confidence in Urine Drug Test Interpretation for Patients with Chronic Pain
verfasst von
Joanna L. Starrels, MD, MS
Aaron D. Fox, MD, MS
Hillary V. Kunins, MD, MPH, MS
Chinazo O. Cunningham, MD, MS
Publikationsdatum
01.11.2012
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 11/2012
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-012-2165-7

Weitere Artikel der Ausgabe 11/2012

Journal of General Internal Medicine 11/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.